These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 7062272)

  • 1. Naloxone without transfusion prolongs survival and enhances cardiovascular function in hypovolemic shock.
    Gurll NJ; Reynolds DG; Vargish T; Lechner R
    J Pharmacol Exp Ther; 1982 Mar; 220(3):621-4. PubMed ID: 7062272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opiate receptors and endorphins in the pathophysiology of hemorrhagic shock.
    Gurll NJ; Vargish T; Reynolds DG; Lechner RB
    Surgery; 1981 Mar; 89(3):364-9. PubMed ID: 6258256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naloxone reversal of hypovolemic shock in dogs.
    Vargish T; Reynolds DG; Gurll NJ; Lechner RB; Holaday JW; Faden AI
    Circ Shock; 1980; 7(1):31-8. PubMed ID: 6248264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naltrexone improves survival rate and cardiovascular function in canine hemorrhagic shock.
    Gurll NJ; Reynolds DG; Vargish T; Lechner R
    J Pharmacol Exp Ther; 1982 Mar; 220(3):625-8. PubMed ID: 6278127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic effects of naloxone in early canine hypovolemic shock.
    Vargish T; Beamer K
    Circ Shock; 1985; 17(1):45-57. PubMed ID: 2996802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adrenalectomy abolishes and cortisol restores naloxone's beneficial effects on cardiovascular function and survival in canine hemorrhagic shock.
    Patton ML; Gurll NJ; Reynolds DG; Vargish T
    Circ Shock; 1983; 10(4):317-27. PubMed ID: 6311454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-dependent effects of nalbuphine in canine hemorrhagic shock.
    Hunt LB; Gurll NJ; Reynolds DG
    Circ Shock; 1984; 13(4):307-18. PubMed ID: 6090033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the autonomic nervous system in mediating the response to naloxone in canine hemorrhagic shock.
    Lechner RB; Gurll NJ; Reynolds DG
    Circ Shock; 1985; 16(3):279-95. PubMed ID: 2865016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naloxone potentiates the cardiovascular effects of catecholamines in canine hemorrhagic shock.
    Lechner RB; Gurll NJ; Reynolds DG
    Circ Shock; 1985; 16(4):347-61. PubMed ID: 3836027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of an opiate antagonist (naloxone) and an agonist/antagonist (nalbuphine) in primate hemorrhagic shock: relationship to catecholamine release.
    McIntosh TK; Palter M; Grasberger R; Vezina R; Yeston NS; Egdahl RH
    Circ Shock; 1985; 17(4):313-25. PubMed ID: 4092345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central nervous system is involved in the cardiovascular responses to naloxone in canine endotoxic but not hemorrhagic shock.
    Gurll NJ; Ganes E; Reynolds DG
    Circ Shock; 1987; 22(2):115-25. PubMed ID: 3594733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effects of oxprenolol on cardiac function during hypovolemic shock in dogs (author's transl)].
    Vormittag E; Keiler A
    Arzneimittelforschung; 1979; 29(10):1534-8. PubMed ID: 583217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic effects of naloxone on hemorrhagic shock in the beagle.
    Toth PD; Hamburger SA; Judy WV
    Circ Shock; 1986; 20(1):35-42. PubMed ID: 3769144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of opiate receptors with naloxone improves survival and cardiac performance in canine endotoxic shock.
    Reynolds DG; Gurll NJ; Vargish T; Lechner RB; Faden AI; Holaday JW
    Circ Shock; 1980; 7(1):39-48. PubMed ID: 6248265
    [No Abstract]   [Full Text] [Related]  

  • 15. Intracoronary naloxone in hemorrhagic shock: dose-dependent stereospecific effects.
    Lechner RB; Gurll NJ; Reynolds DG
    Am J Physiol; 1985 Aug; 249(2 Pt 2):H272-7. PubMed ID: 4025562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late administration of methylprednisolone does not enhance naloxone effect in hypovolemic shock.
    Beamer KC; Daly T; Vargish T
    Circ Shock; 1986; 19(2):221-30. PubMed ID: 3719922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naloxone in endotoxic shock: experimental models and clinical perspective.
    Gurll N
    Adv Shock Res; 1983; 10():63-71. PubMed ID: 6308974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyrotropin releasing hormone: effects in monkeys and dogs subjected to experimental circulatory shock.
    Gurll NJ; Holaday JW; Reynolds DG; Ganes E
    Crit Care Med; 1987 Jun; 15(6):574-81. PubMed ID: 3105962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of temperature on naloxone treatment in canine hemorrhagic shock.
    Horton JW; Tuggle DW; Kiser RS
    Circ Shock; 1984; 14(4):251-65. PubMed ID: 6096039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of naloxone on endotoxic and hemorrhagic shock in horses.
    Weld JM; Kamerling SG; Combie JD; Nugent TE; Woods WE; Oeltgen P; Tobin T
    Res Commun Chem Pathol Pharmacol; 1984 May; 44(2):227-38. PubMed ID: 6739953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.